| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.006 | 0.9 |